Vaishali Pharma’s Q3 FY24 marked by a remarkable 37.59% increase in revenue

Mumbai (Maharashtra) [India], February 7: Vaishali Pharma Limited (NSE – VAISHALI), engaged in production and marketing of a diverse range of pharmaceutical products, announced its unaudited Financial Results for Q3 & 9M FY24.

Key Financials at a Glance: 

Q3 FY24

– Total Income at ₹ 28.37 Cr

– EBITDA at ₹ 3.42 Cr

– EBITDA Margin at 12.05%

– Net Profit at ₹ 2.11 Cr

– NPM (%) at 7.44%

– EPS at ₹ 1.99

9M FY24

– Total Income at ₹ 55.01 Cr

– EBITDA at ₹ 9.05 Cr

– EBITDA Margin at 16.45%

– Net Profit at ₹ 5.4 Cr

– NPM (%) at 9.82%

– EPS at ₹ 5.10

Commenting on the performance, Atul Vasani, Chairman and Managing Director of Vaishali Pharma Limited said, “We are delighted to share our Q3 FY24 results, reflecting our steadfast commitment to innovation, high-quality standards, and strategic global expansion through valuable partnerships. Notably, we introduced our latest brand, “HealthE,” through an online platform, showcasing our dedication to providing health and wellness solutions that enhance lives. Additionally, our participation in CPHI Barcelona (Spain) underscores our active engagement in the global market. Our ongoing collaborations and strategic ventures, including the Nutraceutical Products segment, position us for future growth.

We look forward to advancing our journey towards excellence, prioritizing stakeholder value and contributing significantly to global healthcare improvement.”

Highlights for Q3 FY24 (October 2023 – December 2023)
    The company exhibited at CPHI Barcelona (Spain).CPHI Worldwide is one of the most comprehensive and recognized pharmaceutical exhibitions in the world. The exhibition is divided into six distinct zones, each representing a specific stage of the pharmaceutical supply chain. From APIs and machinery display to outsourcing and biopharmaceuticals, CPHI Worldwide provides a holistic approach to expanding the healthcare industry.
          Introduced brand “HEALTHE” with the online platformUnveiled its latest brand, “HealthE.” This significant development underscores the company’s ongoing dedication to providing health and wellness solutions that enhance lives and foster enduring well-being.   Central to this introduction is the launch of “HealthE Biotin and Multivitamin Gummies,” a groundbreaking product crafted to improve hair, skin, and overall health. These delightful gummies synergize the potency of biotin, vital vitamins, and natural extracts, fostering hair growth, enhancing skin radiance, and elevating overall vitality.
Vaishali Pharma’s Q3 FY24 marked by a remarkable 37.59% increase in revenue

If you have any objection to this press release content, kindly contact to notify us. We will respond and rectify the situation in the next 24 hours.